PHMB — Pharmacom Biovet Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.00m
Annual income statement for Pharmacom Biovet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
1999 December 31st | 2000 December 31st | 2001 December 31st | 2002 December 31st | 2003 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 0 | 18.2 | 0.311 | 0.556 | 0.16 |
Operating Profit | 0 | -18.2 | -0.311 | -0.556 | -0.16 |
Net Income Before Taxes | 0 | -18.2 | -0.311 | -0.556 | -0.16 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0 | -18.2 | -0.311 | -0.556 | -0.16 |
Net Income Before Extraordinary Items | |||||
Net Income | 0 | -18.2 | -0.311 | -0.556 | -0.16 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 0 | -18.2 | -0.311 | -0.556 | -0.16 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0 | -324 | -2.58 | -2.06 | -0.284 |
Dividends per Share |